Innovation leader in Thrombosis and Hemostasis
A complete line for monitoring (when required) New Anticoaglants on citrated plasma:
– Dabigatran, Direct Inhibitor of Thrombin (CE marked)
– Rivaroxaban, Direct Inhibitor of Factor Xa (CE marked)
Zymutest HIA, IgGAM (CE)
Assessment of the risk to develop a HIT complication during heparin therapy by the measurement of the global heparin dependent antibodies, whether the isotype is: IgG, IgA or IgM.
Zymutest HIA, IgG (CE)
Specific measurement of heparin dependent antibodies of the IgG isotype, for the best association with clinical manifestations of HIT and confirmation of this iatrogenic disease.